IDO1 and glioma: In parallel, chemokine gradients (e.g., CCL22, CCL2) actively recruit regulatory T cells (Tregs) to the glioma TME, where they increase further under the effect of immunoregulatory enzymes such as indoleamine 2,3-dioxygenase (IDO) (23).